Lung Cancer Drug Appraisals Showed 56% Cost-Effectiveness Concordance Between Agencies
A comparative study of 35 health technology appraisals found a 56.3% concordance in cost-effectiveness conclusions for lung cancer immunotherapies between ...
A comparative study of 35 health technology appraisals found a 56.3% concordance in cost-effectiveness conclusions for lung cancer immunotherapies between ...
A scoping review of 149 European Reference Network rare disease guidelines revealed a low mean methodological rigor score of 36.2 ...
A systematic review indicates vancomycin regimens rank highest in preventing cranial surgery site infections, though the supporting evidence quality is ...
A United States consensus study identified older adults, high-impact chronic pain, chronic neck pain, function, and cost-effectiveness as top evidence ...
A program evaluation found that individualized instruction in prompt engineering frameworks helped fourth-year medical students confidently query AI systems for ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.